ArticleFrontiers in pharmacology2019

Knockdown of PTGS2 by CRISPR/CAS9 System Designates a New Potential Gene Target for Melanoma Treatment.

Giuseppe Ercolano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.